Objective To investigate the expression of shear factor 3B subunit 1 (SF3B1) gene in pancreatic cancer and its correlation with staging and pathological degree. Methods The clinical data of 48 patients with pancreatic cancer treated by radical operation from the First Affiliated Hospital of Air Force Military Medical University from September 2017 to August 2019 were retrospectively analyzed. Immunohistochemical staining was used to compare the positive rates of SF3B1 gene in pancreatic cancer and paracancerous tissues. According to TNM staging, staging of pancreatic cancer (stage 3, stage II, 11, stage 16, and stage 18) wasdivided into three groups according to the degree of cell differentiation (16 cases of high differentiation, 15 cases of moderate differentiation, 12 cases of poorly differentiated and 5 cases of undifferentiated). The SF3B1 positive rates of different degrees of differentiation and TNM stages of pancreatic cancer were compared. Pearson correlation analysis was used to analyze the relationship between the positive rate of SF3B1 gene and the degree of differentiation and TNM staging of pancreatic cancer. Results The positive rate of sf3b1 gene in adjacent tissues (77.08%) was significantlyhigher than that in cancer tissues (16.67%) (P<0.05). The positive rateof sf3b1 in TNM stages I, II, III and IV was 100.00%, 36.36%, 6.25% and 0.00%, respectively. The positive rate of highly differentiated, moderately differentiated, poorly differentiated and undifferentiated sf3b1 was31.25%, 13.33%, 8.33% and 0.00%, respectively. Pearson analysis showed that the correlation coefficient of SF3B1 gene positive rate with pancreatic cancer differentiation and TNM staging was 0.368 and -0.548 (P<0.001) respectively.Conclusions The positive rate of SF3B1 gene in paracancerous tissues is higher than that in cancer tissues. The positive rate of SF3B1 gene is positively correlated with the degree of differentiation of pancreatic cancer, and the positive rate of SF3B1 gene is negatively correlated with the TNM stage of pancreatic cancer. |